We only have this paper's title and publication details.
Read it at the sourceObservational analysis reveals that the splicing inhibitor H3B-8800 modulates glycolysis and TCA cycle in tumors, implying new therapeutic strategies.
The splicing inhibitor H3B-8800 modulates tumor glycolysis and TCA cycle
No takes yet. Share an insight, caveat, or question.
Chen et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: